FAQ

4-hydroxyatomoxetine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
02420022016

Related topics

Related topics

2 relations

Broader (2)

PhenolsPropylamines

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
4-hydroxyatomoxetine
Phenols
Propylamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Effects of CYP2C19 genetic polymorphisms on atomoxetine pharmacokinetics.
Atomoxetine is a selective norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit/hyperactivity… (More)
Is this relevant?
2013
2013
Concentrations of atomoxetine and its metabolites in plasma and oral fluid from paediatric patients with attention deficit/hyperactivity disorder.
Atomoxetine (ATX) is a non-stimulant drug approved for the treatment of children and adolescents with attention deficit… (More)
  • figure 2
  • figure 1
  • figure 5
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry.
A procedure based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described for determination of atomoxetine (ATX… (More)
  • figure 2
  • table 2
  • table 3
Is this relevant?
2004
2004
Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.
In the studies reported here, the ability of atomoxetine hydrochloride (Strattera) to inhibit or induce the metabolic… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 5
Is this relevant?
2003
2003
Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism.
The role of the polymorphic cytochrome p450 2D6 (CYP2D6) in the pharmacokinetics of atomoxetine hydrochloride [(-)-N-methyl-gamma… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2003
2003
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.
OBJECTIVE Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder in children, adolescents, and… (More)
Is this relevant?
2003
2003
Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog.
These studies were designed to characterize the disposition and metabolism of atomoxetine hydrochloride [(-)-N-methyl-gamma-(2… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2003
2003
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
BACKGROUND AND OBJECTIVES Atomoxetine is a treatment for attention-deficit/hyperactivity disorder and is primarily eliminated via… (More)
Is this relevant?
2002
2002
Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
Studies were performed to determine the human enzymes responsible for the biotransformation of atomoxetine to its major… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2002
2002
Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics.
The purpose of this study was to characterize the effect of potent CYP2D6 inhibition byparoxetine on atomoxetine disposition in… (More)
Is this relevant?